The course of pregnancy and delivery in patients with prolactinoma during treatment with cabergoline
Objectives: To assess the risk of pregnancy and fetal pathology in patients with prolactin-secreting tumors treated with cabergoline in the early stages of gestation.Materials and methods: The study included 24 patients in the age from 24 to 38 years old with prolactin-secreting tumors, become pregn...
Main Authors: | Larisa Dzeranova, Daria Skuridina, Svetlana Vorotnicova, Ekaterina Pigarova |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2016-11-01
|
Series: | Ожирение и метаболизм |
Subjects: | |
Online Access: | https://www.omet-endojournals.ru/jour/article/view/8140 |
Similar Items
-
The efficacy of high-dose cabergoline treatment of prolactinomas resistant to standard doses: a clinical observation
by: Zilya A. Kalmykova, et al.
Published: (2019-09-01) -
Comparative efficacy and safety of generic (Bergolak) vs. brand cabergoline in the treatment of patients with prolactin-secreting tumors
by: Galina Afanas'evna Melnichenko, et al.
Published: (2015-04-01) -
Cabergoline-associated valvulopathy of the tricuspid valve in the treatment of prolactinoma
by: Annabelle G Hayes, et al.
Published: (2023-01-01) -
Clinical Outcome of Invasive Pituitary Prolactinomas Treated with Cabergoline
by: Bassam M Flamerz Arkawazi
Published: (2020-01-01) -
Second attempt of Cabergoline withdrawal in patients with prolactinomas after a failed first attempt : is it worthwhile?
by: Lucio eVilar, et al.
Published: (2015-02-01)